The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE)… (NCT07027891) | Clinical Trial Compass
RecruitingNot Applicable
The Rule-Out Acute Myocardial Infarction Using Aritifical Intelligence Electrocardiogram (ROMIAE) 2 Trial
South Korea4,670 participantsStarted 2025-07-01
Plain-language summary
This study is to see whether the AI ECG assisted protocol is as safe and efficacious as conventional protocol in early triage of suspected myocardial infarction.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* chest pain
* suspicious of acute myocardial infarction
Exclusion Criteria:
* STEMI
* Revisit of same symptoms within 1 week
* traumatic chest pain
* Pneumothorax
* Transferred from other hospital diagnosed of AMI
* Cardiac arrest
* Chest pain of clearly non-cardiac etiology
* declined to participate in the study
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial uses an AI-analyzed ECG to help rule out a heart attack — how accurate is this AI technology compared to the standard tests I'd normally receive in the ER, and could relying on it mean anything gets missed in my case?
2Since the trial is tracking major adverse cardiac events like another heart attack or death over 30 days, what happens if I experience one of those events during that window — will I still have full access to standard emergency care?
3This study is listed as 'Phase NA,' which typically means it's evaluating a diagnostic tool rather than a new drug or procedure — does that change the risk profile for me compared to a traditional treatment trial, and what would actually be different about my care if I participated?
4If the AI ECG suggests my chest pain is not a heart attack, would I still receive the usual blood tests and monitoring that my care team would normally order, or could a negative AI result lead to me being discharged sooner than I otherwise would be?
5Given that this trial is actively recruiting right now, are there standard chest pain evaluation pathways or existing AI-assisted diagnostic tools already approved that I should consider first before deciding whether to enroll?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.